Tony Abbott has serious concerns with the Japanese bid for defence contract Russia launches largest drone and missile attack ...

Australia's batting woes exposed by West Indies as Pat Cummins moment stuns cricket world Scientists discover new entity that ...

UBS remains bullish on Eli Lilly’s future thanks to surging demand for its obesity and diabetes treatments. UBS predicts Zepbound sales could exceed market expectations by roughly 15%. Meanwhile, ...

Eli Lilly & Company (NYSE:LLY) ranks among the best set-it-and-forget-it stocks to buy. On June 27, UBS kept its Buy rating ...